BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 10, 2007
View Archived Issues
Targeting TRPV1 for the treatment of type 1 diabetes
Read More
Sirolimus to be tested in clinical trial for ALPS / News in Context
Read More
Novartis reports positive preclinical results of novel Nurr1 activator
Read More
Targepeutics developing targeted molecular therapies for cancer
Read More
NEOSH-101 increases hair growth significantly in men with androgenetic alopecia
Read More
Refrigerated formulation of FluMist receives FDA approval
Read More
Depression and anxiety compound TC-2216 begins phase I trial
Read More
New phase II study evaluates R-788 in ITP
Read More
Interim analysis clears pivotal study of pralatrexate to continue
Read More
Phase II/III pain program outlined for Anesiva's 4975
Read More
Alkermes and Lilly sign manufacturing agreement for AIR Inhaled Insulin
Read More
Genentech and Seattle Genetics sign worldwide license agreement for SGN-40
Read More
Bayer and Berlex combine businesses in Canada
Read More
Boehringer Ingelheim and Ablynx to develop Nanobodies for Alzheimer's
Read More
New phase II trial studies nemonoxacin for CAP
Read More
ZEN-012 begins phase I study in solid tumors and lymphoma
Read More
Patents disclose therapeutic agents for schizophrenia, depression and other psychological disorders
Read More
Novel antiinfective agents disclosed in recent AstraZeneca and Novozymes patents
Read More
New vitamin D3 receptor agonists prepared and tested at Chugai
Read More
CAT grants iCo license to CAT-213
Read More
Pierre Fabre acquires UCB's OTC business in certain countries
Read More
deCODE genetics updates development programs
Read More
European approval for once-weekly NeoRecormon
Read More
Orphan drug designation for PV-10 in metastatic melanoma
Read More
